ArticleNanomaterials (Basel, Switzerland)2022
Novel MOF-Based Photocatalyst AgBr/AgCl@ZIF-8 with Enhanced Photocatalytic Degradation and Antibacterial Properties.
Article in Nanomaterials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Monolithic AgX/Biomass Carbon Aerogels (X = Br, Cl) for Recyclable Photocatalytic Degradation of Multiple Pollutant Classes.Gels (Basel, Switzerland) · 2026Article
- Z-Scheme ZIF-8/AgMaterials (Basel, Switzerland) · 2025Article
- Peroxydisulfate-assisted sonocatalytic degradation of metribuzin by La-doped ZnFe layered double hydroxide.Ultrasonics sonochemistry · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
A novel visible light-driven AgBr/AgCl@ZIF-8 catalyst was synthesized by a simple and rapid method. The composition and structure of the photocatalyst were characterized by XRD, SEM, UV-DRS, and XPS. It could be observed that the 2-methylimidazole zinc salt (ZIF-8) exhibited the rhombic dodecahedron morphology with the AgCl and AgBr particles evenly distributed around it. The composite photocatalyst AgBr/AgCl@ZIF-8 showed good photocatalytic degradation and antibacterial properties. The degradation rate of RhB solution was 98%, with 60 min of irradiation of visible light, and almost all
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.